GBIM / GlobeImmune, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

GlobeImmune, Inc.
US ˙ OTCPK

Deler fremragende 5,751,574 shares
Insideraktier2.395.500 shares
Insider ejerskab41,65 %
Total Insiders11
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
7027 out of 10945

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
7173 out of 10814

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

GlobeImmune, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Celgene International Inc 10% Owner - [10%] 600.670 600.670
Kirk A Christoffersen VP, Corporate Development - [O] 2.389 2.389
Dekker C. Jeffrey 11.772
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
J William Freytag 1.697
Healthcare Ventures Vii Lp - 554.267 554.267
Augustine Lawlor Director, 10% Owner - [D] [10%] 463.267 463.267
Daniel J Mitchell Director - [D] 836 836
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Morgenthaler Partners Vii Lp 10% Owner - [10%] 530.461 530.461
Timothy C Jr Rodell CEO & Pres, Director - [D] [O] 1.904 1.904
Pennina Safer 0
Torres S. Edward Director - [D] 241.706 241.706

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i GBIM / GlobeImmune, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2014-07-08 MITCHELL DANIEL J 10.000 10,0000 10.000 10,0000 100.000 3 14.79 47.900 47,90
2014-07-08 MITCHELL DANIEL J 75.000 10,0000 75.000 10,0000 750.000
2014-07-08 RODELL TIMOTHY C JR 5.000 10,0000 5.000 10,0000 50.000
2014-07-08 MORGENTHALER PARTNERS VII LP 130.000 10,0000 130.000 10,0000 1.300.000
2014-07-08 HEALTHCARE VENTURES VII LP 190.000 10,0000 190.000 10,0000 1.900.000
2014-07-08 Celgene International Inc 200.000 10,0000 200.000 10,0000 2.000.000
2014-07-08 Torres S. Edward 85.000 10,0000 85.000 10,0000 850.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

GBIM / GlobeImmune, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i GBIM / GlobeImmune, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2016-03-18 LAWLOR AUGUSTINE 11.000 1,5500 11.000 1,5500 17.050 342 0.14 -15.510 -90,97
2016-03-17 Torres S. Edward 26.188 1,6663 26.188 1,6663 43.637
2016-03-17 MITCHELL DANIEL J 12.468 1,5203 12.468 1,5203 18.955
2016-03-17 MITCHELL DANIEL J 158 1,5203 158 1,5203 240
2016-03-16 MITCHELL DANIEL J 8.862 1,8509 8.862 1,8509 16.403
2016-03-16 MITCHELL DANIEL J 112 1,8509 112 1,8509 207
2016-03-15 LAWLOR AUGUSTINE 2.500 2,0500 2.500 2,0500 5.125
2016-03-15 MITCHELL DANIEL J 50.831 2,1680 50.831 2,1680 110.202
2016-03-15 MITCHELL DANIEL J 645 2,1680 645 2,1680 1.398

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

GBIM / GlobeImmune, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2016-03-21 2016-03-17 4 Torres S. Edward By Lilly Ventures Fund I, LLC GBIM Common Stock S - Sale I 1,6663 -26.188 -44 241.706
2016-03-18 2016-03-17 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,5203 -158 -0 836
2016-03-18 2016-03-17 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,5203 -12.468 -19 65.958
2016-03-18 2016-03-16 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,8509 -112 -0 994
2016-03-18 2016-03-16 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,8509 -8.862 -16 78.426
2016-03-18 2016-03-18 4 LAWLOR AUGUSTINE By Partnership GBIM Common Stock S - Sale I 1,5500 -11.000 -17 463.267
2016-03-17 2016-03-15 4 LAWLOR AUGUSTINE By Partnership GBIM Common Stock S - Sale I 2,0500 -2.500 -5 474.267
2016-03-15 2016-03-15 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 2,1680 -645 -1 1.106
2016-03-15 2016-03-15 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 2,1680 -50.831 -110 87.288
2016-03-15 2016-03-11 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 2,3153 -2.131 -5 1.751
2016-03-15 2016-03-11 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 2,3153 -76.662 -177 138.119
2016-03-14 2016-03-11 4 LAWLOR AUGUSTINE By Partnership GBIM Common Stock S - Sale I 1,6000 -16.300 -26 476.767
2016-03-14 2016-03-10 4 LAWLOR AUGUSTINE By Partnership GBIM Common Stock S - Sale I 1,3500 -200 -0 493.067
2016-03-10 2016-03-10 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,1587 -127 -0 3.882
2016-03-10 2016-03-10 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,1587 -4.573 -5 214.781
2016-03-10 2016-03-09 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,2091 -157 -0 4.009
2016-03-10 2016-03-09 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,2091 -5.643 -7 219.354
2016-03-10 2016-03-08 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,1402 -159 -0 4.166
2016-03-10 2016-03-08 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,1402 -5.741 -7 224.997
2016-03-08 2016-03-08 4 LAWLOR AUGUSTINE By Partnership GBIM Common Stock S - Sale I 1,1000 -5.000 -6 493.267
2016-03-08 2016-03-07 4 LAWLOR AUGUSTINE By Partnership GBIM Common Stock S - Sale I 0,9900 -5.010 -5 498.267
2016-03-08 2016-03-04 4 LAWLOR AUGUSTINE By Partnership GBIM Common Stock S - Sale I 1,0500 -5.000 -5 503.277
2016-03-07 2016-03-07 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,0726 -100 -0 4.325
2016-03-07 2016-03-07 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,0726 -3.600 -4 230.738
2016-03-07 2016-03-04 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,0181 -176 -0 4.425
2016-03-07 2016-03-04 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,0181 -6.344 -6 234.338
2016-03-07 2016-03-03 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,1194 -46 -0 4.601
2016-03-07 2016-03-03 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,1194 -1.654 -2 240.682
2016-03-03 2016-03-03 4 LAWLOR AUGUSTINE By Partnership GBIM Common Stock S - Sale I 1,1500 -990 -1 508.277
2016-03-03 2016-03-02 4 LAWLOR AUGUSTINE By Partnership GBIM Common Stock S - Sale I 1,1900 -10.000 -12 509.267
2016-03-03 2016-03-01 4 LAWLOR AUGUSTINE By Partnership GBIM Common Stock S - Sale I 0,9400 -5.000 -5 519.267
2016-03-02 2016-03-02 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,1682 -152 -0 4.647
2016-03-02 2016-03-02 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,1682 -5.471 -6 242.336
2016-03-02 2016-03-01 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 0,9558 -238 -0 4.799
2016-03-02 2016-03-01 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 0,9558 -8.561 -8 247.807
2016-03-02 2016-02-29 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 0,9542 -81 -0 5.037
2016-03-02 2016-02-29 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 0,9542 -2.919 -3 256.368
2016-02-29 2016-02-29 4 LAWLOR AUGUSTINE By Partnership GBIM Common Stock S - Sale I 0,8900 -5.000 -4 524.267
2016-02-29 2016-02-26 4 LAWLOR AUGUSTINE By Partnership GBIM Common Stock S - Sale I 1,0000 -5.000 -5 529.267
2016-02-29 2016-02-25 4 LAWLOR AUGUSTINE By Partnership GBIM Common Stock S - Sale I 1,0500 -5.000 -5 534.267
2016-02-26 2016-02-26 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 0,9466 -181 -0 5.118
2016-02-26 2016-02-26 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 0,9466 -6.520 -6 259.287
2016-02-26 2016-02-25 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,0632 -56 -0 5.299
2016-02-26 2016-02-25 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,0632 -2.003 -2 265.807
2016-02-26 2016-02-24 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,1676 -101 -0 5.355
2016-02-26 2016-02-24 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,1676 -3.640 -4 267.810
2016-02-24 2016-02-24 4 LAWLOR AUGUSTINE By Partnership GBIM Common Stock S - Sale I 1,1700 -5.000 -6 539.267
2016-02-24 2016-02-23 4 LAWLOR AUGUSTINE By Partnership GBIM Common Stock S - Sale I 1,3900 -5.000 -7 544.267
2016-02-24 2016-02-22 4 LAWLOR AUGUSTINE By Partnership GBIM Common Stock S - Sale I 1,4300 -5.000 -7 549.267
2016-02-23 2016-02-23 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,3600 -73 -0 5.456
2016-02-23 2016-02-23 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,3600 -2.627 -4 271.450
2016-02-23 2016-02-22 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,4264 -157 -0 5.529
2016-02-23 2016-02-22 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,4264 -5.643 -8 274.077
2016-02-23 2016-02-19 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,4318 -388 -1 5.686
2016-02-23 2016-02-19 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,4318 -13.970 -20 279.720
2016-02-19 2016-02-19 4 HEALTHCARE VENTURES VII LP By Partnership GBIM Common Stock S - Sale I 1,3900 -5.000 -7 554.267
2016-02-19 2016-02-18 4 HEALTHCARE VENTURES VII LP By Partnership GBIM Common Stock S - Sale I 1,4000 -5.000 -7 559.267
2016-02-19 2016-02-17 4 HEALTHCARE VENTURES VII LP By Partnership GBIM Common Stock S - Sale I 1,5300 -5.000 -8 564.267
2016-02-18 2016-02-18 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,4179 -322 -0 6.074
2016-02-18 2016-02-18 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,4179 -11.600 -16 293.690
2016-02-18 2016-02-17 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,4749 -214 -0 6.396
2016-02-18 2016-02-17 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,4749 -7.720 -11 305.290
2016-02-18 2016-02-16 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,4956 -55 -0 6.610
2016-02-18 2016-02-16 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,4956 -1.986 -3 313.010
2016-02-16 2016-02-16 4 HEALTHCARE VENTURES VII LP By Partnership GBIM Common Stock S - Sale I 1,5100 -5.000 -8 569.267
2016-02-16 2016-02-12 4 HEALTHCARE VENTURES VII LP By Partnership GBIM Common Stock S - Sale I 1,5900 -5.000 -8 574.267
2016-02-16 2016-02-11 4 HEALTHCARE VENTURES VII LP By Partnership GBIM Common Stock S - Sale I 1,7200 -5.000 -9 579.267
2016-02-12 2016-02-12 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,5896 -34 -0 6.665
2016-02-12 2016-02-12 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,5896 -1.216 -2 314.996
2016-02-12 2016-02-11 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,7229 -32 -0 6.699
2016-02-12 2016-02-11 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,7229 -1.163 -2 316.212
2016-02-12 2016-02-10 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,9308 -32 -0 6.731
2016-02-12 2016-02-10 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,9308 -1.168 -2 317.375
2016-02-09 2016-02-09 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 1,9912 -76 -0 6.763
2016-02-09 2016-02-09 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 1,9912 -2.724 -5 318.543
2016-02-09 2016-02-08 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 2,0077 -87 -0 6.839
2016-02-09 2016-02-08 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 2,0077 -3.113 -6 321.267
2016-02-09 2016-02-05 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock S - Sale I 2,2785 -35 -0 6.926
2016-02-09 2016-02-05 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock S - Sale I 2,2785 -1.265 -3 324.380
2015-07-13 2015-07-09 4 LAWLOR AUGUSTINE GBIM Stock Option (Right to Buy) A - Award D 2,56 1.697 1.697
2015-07-13 2015-07-09 4 FREYTAG J WILLIAM GBIM Stock Option (right to buy) A - Award D 2,56 1.697 1.697
2015-07-13 2015-07-09 4 Torres S. Edward GBIM Stock Option (right to buy) A - Award D 2,56 1.697 1.697
2015-07-13 2015-07-09 4 MITCHELL DANIEL J GBIM Stock Option (right to buy) A - Award D 2,56 1.697 1.697
2015-04-10 3/A RODELL TIMOTHY C JR By SMG, Inc. GBIM Common Stock I 1.904
2015-01-08 2015-01-06 4 Christoffersen Kirk A GBIM Stock Option (right to buy) A - Award D 7,71 11.773 11.773
2015-01-08 2015-01-06 4 RODELL TIMOTHY C JR GBIM Stock Option (right to buy) A - Award D 7,71 39.480 39.480
2015-01-08 2015-01-06 4 Dekker C. Jeffrey GBIM Stock Option (right to buy) A - Award D 7,71 11.772 11.772
2014-12-17 2014-12-15 4 Christoffersen Kirk A GBIM Stock Option (right to buy) M - Exercise D 4,73 -2.389 0
2014-12-17 2014-12-15 4 Christoffersen Kirk A GBIM Common Stock M - Exercise D 4,7300 2.389 11 2.389
2014-07-15 2014-07-08 4/A Torres S. Edward By Lilly Ventures Fund I, LLC GBIM Warrant to Purchase Common Stock (right to buy) C - Conversion I 45,36 1.614 1.614
2014-07-15 2014-07-08 4/A MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Warrant to Purchase Common Stock (right to buy) C - Conversion I 45,36 2.133 2.133
2014-07-15 2014-07-08 4/A MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Warrant to Purchase Common Stock (right to buy) C - Conversion I 45,36 59 59
2014-07-15 2014-07-08 4/A MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Warrant to Purchase Common Stock (right to buy) C - Conversion I 42,00 2.675 2.675
2014-07-15 2014-07-08 4/A MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Warrant to Purchase Common Stock (right to buy) C - Conversion I 42,00 74 74
2014-07-09 2014-07-08 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Warrant to Purchase Common Stock (right to buy) C - Conversion I 45,36 2.133 2.133
2014-07-09 2014-07-08 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Warrant to Purchase Common Stock (right to buy) C - Conversion I 45,36 59 59
2014-07-09 2014-07-08 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Warrant to Purchase Common Stock (right to buy) C - Conversion I 42,00 2.675 2.675
2014-07-09 2014-07-08 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Warrant to Purchase Common Stock (right to buy) C - Conversion I 42,00 74 74
2014-07-09 2014-07-08 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Warrant to Purchase Series C Preferred Stock (right to buy) C - Conversion I 1,4450 -66.955 -97 0
2014-07-09 2014-07-08 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Warrant to Purchase Series C Preferred Stock (right to buy) C - Conversion I 1,4450 -1.860 -3 0
2014-07-09 2014-07-08 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Warrant to Purchase Series B Preferred Stock (right to buy) C - Conversion I 1,3380 -83.988 -112 0
2014-07-09 2014-07-08 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Warrant to Purchase Series B Preferred Stock (right to buy) C - Conversion I 1,3380 -2.334 -3 0
2014-07-09 2014-07-08 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Series E Convertible Preferred Stock C - Conversion I -788.205 0
2014-07-09 2014-07-08 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Series E Convertible Preferred Stock C - Conversion I -21.905 0
2014-07-09 2014-07-08 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Series C Convertible Preferred Stock C - Conversion I -2.710.122 0
2014-07-09 2014-07-08 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Series C Convertible Preferred Stock C - Conversion I -75.318 0
2014-07-09 2014-07-08 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Series B Convertible Preferred Stock C - Conversion I -3.054.134 0
2014-07-09 2014-07-08 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Series B Convertible Preferred Stock C - Conversion I -84.879 0
2014-07-09 2014-07-08 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Series A Convertible Preferred Stock C - Conversion I -1.315.441 0
2014-07-09 2014-07-08 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Series A Convertible Preferred Stock C - Conversion I -36.557 0
2014-07-09 2014-07-08 4 MITCHELL DANIEL J GBIM Common Stock P - Purchase D 10,0000 10.000 100 10.000
2014-07-09 2014-07-08 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock P - Purchase I 10,0000 75.000 750 325.645
2014-07-09 2014-07-08 4 MITCHELL DANIEL J By Sequel Limited Partnership III GBIM Common Stock C - Conversion I 250.645 250.645
2014-07-09 2014-07-08 4 MITCHELL DANIEL J By Sequel Entrepreneurs Fund III, LP GBIM Common Stock C - Conversion I 6.961 6.961
2014-07-09 2014-07-08 4 RODELL TIMOTHY C JR GBIM Common Stock P - Purchase D 10,0000 5.000 50 5.000
2014-07-09 2014-07-08 4 MORGENTHALER PARTNERS VII LP GBIM Warrant to Purchase Common Stock (right to buy) C - Conversion D 45,36 3.714 3.714
2014-07-09 2014-07-08 4 MORGENTHALER PARTNERS VII LP GBIM Warrant to Purchase Common Stock (right to buy) C - Conversion D 42,00 5.172 5.172
2014-07-09 2014-07-08 4 MORGENTHALER PARTNERS VII LP GBIM Warrant to Purchase Series C Preferred Stock (right to buy) C - Conversion D 1,4450 -116.586 -168 0
2014-07-09 2014-07-08 4 MORGENTHALER PARTNERS VII LP GBIM Warrant to Purchase Series B Preferred Stock (right to buy) C - Conversion D 1,3380 -162.369 -217 0
2014-07-09 2014-07-08 4 MORGENTHALER PARTNERS VII LP GBIM Series E Convertible Preferred Stock C - Conversion D -259.235 0
2014-07-09 2014-07-08 4 MORGENTHALER PARTNERS VII LP GBIM Series C Convertible Preferred Stock C - Conversion D -3.879.015 0
2014-07-09 2014-07-08 4 MORGENTHALER PARTNERS VII LP GBIM Series B Convertible Preferred Stock C - Conversion D -5.904.335 0
2014-07-09 2014-07-08 4 MORGENTHALER PARTNERS VII LP GBIM Series A Convertible Preferred Stock C - Conversion D -2.528.000 0
2014-07-09 2014-07-08 4 MORGENTHALER PARTNERS VII LP GBIM Common Stock P - Purchase D 10,0000 130.000 1.300 530.461
2014-07-09 2014-07-08 4 MORGENTHALER PARTNERS VII LP GBIM Common Stock C - Conversion D 400.461 400.461
2014-07-09 2014-07-08 4 Torres S. Edward By Lilly Ventures Fund I, LLC GBIM Warrant to Purchase Common Stock (right to buy) C - Conversion I 45,36 1.614 1.614
2014-07-09 2014-07-08 4 Torres S. Edward By Lilly Ventures Fund I, LLC GBIM Warrant to Purchase Series C Preferred Stock (right to buy) C - Conversion I 1,4450 -50.684 -73 0
2014-07-09 2014-07-08 4 Torres S. Edward By Lilly Ventures Fund I, LLC GBIM Series E Convertible Preferred Stock C - Conversion I -318.411 0
2014-07-09 2014-07-08 4 Torres S. Edward By Lilly Ventures Fund I, LLC GBIM Series C Convertible Preferred Stock C - Conversion I -1.685.796 0
2014-07-09 2014-07-08 4 Torres S. Edward By Lilly Ventures Fund I, LLC GBIM Series B Convertible Preferred Stock C - Conversion I -3.736.921 0
2014-07-09 2014-07-08 4 Torres S. Edward By Lilly Ventures Fund I, LLC GBIM Common Stock P - Purchase I 10,0000 85.000 850 267.894
2014-07-09 2014-07-08 4 Torres S. Edward By Lilly Ventures Fund I, LLC GBIM Common Stock C - Conversion I 182.894 182.894
2014-07-08 2014-07-08 4 HEALTHCARE VENTURES VII LP By Partnership GBIM Series E Convertible Preferred Stock C - Conversion I -64.809 0
2014-07-08 2014-07-08 4 HEALTHCARE VENTURES VII LP By Partnership GBIM Series C Convertible Preferred Stock C - Conversion I -3.879.015 0
2014-07-08 2014-07-08 4 HEALTHCARE VENTURES VII LP By Partnership GBIM Series B Convertible Preferred Stock C - Conversion I -5.904.335 0
2014-07-08 2014-07-08 4 HEALTHCARE VENTURES VII LP By Partnership GBIM Series A Convertible Preferred Stock C - Conversion I -2.528.000 0
2014-07-08 2014-07-08 4 HEALTHCARE VENTURES VII LP By Partnership GBIM Common Stock P - Purchase I 10,0000 190.000 1.900 584.267
2014-07-08 2014-07-08 4 HEALTHCARE VENTURES VII LP By Partnership GBIM Common Stock C - Conversion I 2.064 394.267
2014-07-08 2014-07-08 4 HEALTHCARE VENTURES VII LP By Partnership GBIM Common Stock C - Conversion I 123.574 392.203
2014-07-08 2014-07-08 4 HEALTHCARE VENTURES VII LP By Partnership GBIM Common Stock C - Conversion I 188.096 268.629
2014-07-08 2014-07-08 4 HEALTHCARE VENTURES VII LP By Partnership GBIM Common Stock C - Conversion I 80.533 80.533
2014-07-08 2014-07-08 4 Celgene International Inc GBIM Series E Convertible Preferred Stock C - Conversion D -1.765.888 0
2014-07-08 2014-07-08 4 Celgene International Inc GBIM Series D Convertible Preferred Stock C - Conversion D -8.650.519 0
2014-07-08 2014-07-08 4 Celgene International Inc GBIM Series C Convertible Preferred Stock C - Conversion D -2.160.682 0
2014-07-08 2014-07-08 4 Celgene International Inc GBIM Common Stock P - Purchase I 10,0000 200.000 2.000 600.670
2014-07-08 2014-07-08 4 Celgene International Inc GBIM Common Stock C - Conversion D 56.256 400.670
2014-07-08 2014-07-08 4 Celgene International Inc GBIM Common Stock C - Conversion D 275.582 344.414
2014-07-08 2014-07-08 4 Celgene International Inc GBIM Common Stock C - Conversion D 68.832 68.832
2014-07-01 3 RODELL TIMOTHY C JR By SMG, Inc. GBIM Common Stock I 2.188
2014-07-01 3 RODELL TIMOTHY C JR By SMG, Inc. GBIM Common Stock I 2.188
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista